Clinical Cancer Research, Vol 4, Issue 9 2179-2186, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis

C Caenazzo, M Onisto, L Sartor, R Scalerta, A Giraldo, D Nitti and S Garbisa
Institute of Histology and Embryology, Medical School of Padova, Italy.

The activation of zymogen and the amount of proteinase and its inhibition are important in determining the eventual activity of matrix-degrading enzymes involved in tumor aggressiveness. To evaluate a gene complement leading to matrix metalloproteinase 2 (MMP-2; Mr 72,000 gelatinase) activity, membrane type 1 MMP (MT1-MMP), urokinase-type plasminogen activator, MMP-2, and tissue inhibitor of metalloproteinase 2 transcriptional levels were measured in gastric carcinoma biopsies. Comparative tumor:normal tissue reverse transcription-PCR in a cohort of 25 patients revealed up to a 10-fold difference in the expression of MT1-MMP, a metalloproteinase that has been proposed as a membrane receptor activator of MMP-2; a 1-unit increment resulted in a 30% risk to survival. A 20% risk also resulted from a 1-unit increment in the MT1-MMP: MMP-2 ratio, which showed differences of up to 15-fold. Instead, the expression of urokinase-type plasminogen activator, which trips off a cascade ending in the activation of MMP-2, as well as the expression of MMP-2 itself and its inhibitor, tissue inhibitor of metalloproteinase 2, lacked correlation with patient follow-up. Zymography revealed MMP-2 activities that were often in conflict with the transcription results and also with follow-up. The results suggest the evaluation of MT1-MMP and/or MT1-MMP:MMP-2 transcription as a new preoperative molecular-level prognostic factor for gastric carcinoma.

This article has been cited by other articles:

				A. Parenti, L. Brogelli, S. Filippi, S. Donnini, and F. Ledda Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1 Cardiovasc Res, July 1, 2002; 55(1): 201 - 212. [Abstract] [Full Text] [PDF]

				P. Mene, C. Caenazzo, F. Pugliese, G. A. Cinotti, A. D'Angelo, S. Garbisa, and G. Gambaro Monocyte/mesangial cell interactions in high-glucose co-cultures Nephrol. Dial. Transplant., May 1, 2001; 16(5): 913 - 922. [Abstract] [Full Text] [PDF]

				T Etoh, H Inoue, Y Yoshikawa, G F Barnard, S Kitano, and M Mori Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness Gut, July 1, 2000; 47(1): 50 - 56. [Abstract] [Full Text] [PDF]

				M. Määttä, Y. Soini, A. Liakka, and H. Autio-Harmainen Differential Expression of Matrix Metalloproteinase (MMP)-2, MMP-9, and Membrane Type 1-MMP in Hepatocellular and Pancreatic Adenocarcinoma: Implications for Tumor Progression and Clinical Prognosis Clin. Cancer Res., July 1, 2000; 6(7): 2726 - 2734. [Abstract] [Full Text]